Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...
Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s ...
The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.
Attruby's approval makes BridgeBio Pharma a competitor to Vyndaqel, with significant potential for growth and milestone ...
The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...
The FDA announced on Wednesday that it has banned the use of Red No. 3, an additive used to give food and drinks a cherry-red ...
Eli Lilly (LLY) announced that the FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease in adults. Omvoh ...
The ban removes it from the list of approved color additives in foods, dietary supplements and oral medicines, such as cough ...
With Wednesday's ban of Red No. 3, there are now 8 artificial dyes in America's food supply. Discover what dyes remain, the ...
Eli Lilly (NYSE:LLY) has received FDA approval for its drug Omvoh, also known as mirikizumab-mrkz, for the treatment of ...
Manufacturers who use Red No. 3 in food will have until Jan. 15, 2027 to reformulate their products, while those who use the ...
Thousands of foods contain Red Dye No. 3, the substance banned by U.S. regulators on Wednesday due to potential cancer links.